Скачать
Industry Update: Avidity
Автор: DefeatDuchenne
Загружено: 2025-12-11
Просмотров: 5
Описание:
On December 3, Defeat Duchenne Canada hosted an Industry Partner Update with Avidity Biosciences, featuring Elizabeth (Lisa) Ackermann, Senior Vice President of Clinical Development.
Avidity presented new topline and functional data from the EXPLORE44-OLE® clinical trial, highlighting progress on their investigational therapy delpacibart zotadirsen (del-zota) for individuals with Duchenne muscular dystrophy mutations amenable to exon 44 skipping (DMD44).
Stay informed about upcoming Duchenne research updates and webinars at https://defeatduchenne.ca/webinars.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
